Is duplex surveillance of value after leg vein bypass grafting? Principal results of the vein graft surveillance randomised trial (VGST)

Circulation

Volumn 112, Issue 13, 2005, Pages 1985-1991

  Davies, Alun H ^a   Hawdon, A J ^a   Sydes, M R ^b   Thompson, S G ^c  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Amputation; Grafting; Imaging; Occlusion; Stenosis

Indexed keywords

AMPUTATION; ARTICLE; BYPASS SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FEMOROCRURAL VEIN BYPASS; FEMOROPOPLITEAL BYPASS; FOLLOW UP; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; LEG THROMBOSIS; LEG VEIN; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VEIN GRAFT;

AGED; AMPUTATION; BLOOD VESSEL PROSTHESIS; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; LEG; MALE; MIDDLE AGED; MORTALITY; POPULATION SURVEILLANCE; QUALITY OF LIFE; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY; VEINS;

EID: 25444494518     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.518738     Document Type: Article

References (40)

1. Sayers RD, Raptis S, Berce M, Miller JH. Long-term results of femorotibial bypass with vein or polytetrafluoroethylene. Br J Surg. 1998;85: 934-938.
2. Moody P, DeCossart LM, Douglas HM, Harris PL. Asymptomatic strictures in femoropopliteal vein grafts. Eur J Vasc Surg. 1989;75: 737-740.
3. Szilagyi DE, Elliott JP, Hageman JH, Smith RF, Dall'olmo CA. Biologic fate of autogenous vein implants as arterial substitutes: clinical, angiographic and histopathologic observations in femoro-popliteal operations for atherosclerosis. Ann Surg. 1973; 178:232-246.
4. Mills JL. Mechanisms of vein graft failure: the location, distribution, and characteristics of lesions that predispose to graft failure. Semin Vasc Surg. 1993;6:78-91.
5. Golledge J, Beattie DK, Greenhalgh RM, Davies AH. Have the results of infrainguinal bypass improved with the widespread utilisation of postoperative surveillance? Eur J Vasc Endovasc Surg. 1996;11:388-392.
6. Davies AH, Magee TR, Tennant SGW, Baird RN, Horrocks M. Criteria for identification of the "at risk" infrainguinal bypass graft. Eur J Vasc Surg. 1994;8:315-319.
7. Moody P, Gould DA, Harris PL. Vein graft surveillance improves patency in femoropopliteal bypass. Eur J Vasc Surg. 1990;4:117-121.
8. Grigg MJ, Nicolaides AN, Wolfe JH. Detection and grading of femorodistal vein graft stenoses: duplex velocity measurements compared with angiography. J Vasc Surg. 1988;8:661-666.
9. Wolfe JH, Thomas ML, Jamieson CW, Browse NL, Burnand KG, Rutt DL. Early diagnosis of femorodistal graft stenoses. Br J Surg. 1987;74: 268-270.
10. Bandyk DF, Kaebnick HW, Stewart GW, Towne JB. Durability of the in situ saphenous vein arterial bypass: a comparison of primary and secondary patency. J Vasc Surg. 1987;5:256-268.
11. Berkowitz HD, Greenstein SM. Improved patency in reversed femoral-infrapopliteal autogenous vein grafts by early detection and treatment of the failing graft. J Vasc Surg. 1987;5:755-761.
12. Gibbs RGJ, Beattie DK, Greenhalgh RM, Davies AH. Vein graft surveillance: current trends. Br J Surg. 1997;84:63.
13. Grigg M, Nicolaides AN, Wolfe JH. Can postoperative surveillance of femoro-distal vein grafts be justified? In: Greenhalgh RM, Jamieson CW, Nicolaides AN, eds. Limb Salvage and Amputation in Vascular Disease. Philadelphia, Pa: WB Saunders; 1988:259-270.
14. Nehler MR, Moneta GL, Yeager RA, Edwards JM, Taylor LMJ, Porter JM. Surgical treatment of threatened reversed infrainguinal vein grafts. J Vasc Surg. 1994;20:558-563.
15. Nielsen TG. Natural history of infrainguinal vein bypass stenoses: early lesions increase the risk of thrombosis. Eur J Vasc Endovasc Surg. 1996;12:60-64.
16. Lundell A, Lindblad B, Bergqvist D, Hansen F. Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study. J Vasc Surg. 1995;21:26-33.
17. Ihlberg L, Luther M, Tierala E, Lepantalo M. The utility of duplex scanning in infra-inguinal vein graft surveillance: results from a randomised controlled study. Eur J Vasc Endovasc Surg. 1998;16:19-27.
18. Ihlberg L, Luther M, Alback A, Kantonen I, Lepantalo M. Does a completely accomplished duplex-based surveillance prevent vein-graft failure? Eur J Vasc Endovasc Surg. 1999;18:395-400.
19. Kirby PL, Brady AR, Thompson SG, Torgerson D, Davies AH. The Vein Graft Surveillance Trial: rationale, design and methods. Eur J Vasc Endovasc Surg. 1999;18:469-474.
20. Idu MM, Buth J, Cuypers P, Hop WC, van de Pavoordt ED, Tordoir JM. Economising vein-graft surveillance programs. Eur J Vasc Endovasc Surg. 1998;15:432-438.
21. Mills JL, Bandyk DF, Gathan V, Esses G. The origin of infrainguinal vein graft stenosis: a prospective randomized trial based on duplex surveillance. J Vasc Surg. 1995;21:16-25.
22. McCarthy MJ, Olojugba D, Loftus IM, Naylor AR, Bell PR, London NJ. Lower limb surveillance following autologous vein bypass should be life long. Br J Surg. 1998;85:1369-1372.
23. TransAtlantic Inter-Society Consensus. Eur J Vasc Endovasc Surg. 2000; 19:216-218.
24. Bandyk DF, Cato RF, Towne JB. A low flow velocity predicts failure of femoropopliteal and femorotibial bypass grafts. Surgery. 1985;98: 799-809.
25. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517-538.
26. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ. 1993;306:1440-1444.
27. Brazier J, Jones N, Kind P. Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993;2:169-180.
28. van Agt AH, Essink-Bot ML, Krabbe PF, Bonsel GJ. Test-retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med. 1994;39:1537-1544.
29. Available at: http://www.dh.gov.uk/PublicationsAndStatistics/Publica tions/. Accessed September, 2004.
30. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ. 2000;320:1197-1200.
31. Hawdon AJ, Davies AH. Vein graft surveillance: is the yield worth the effort? Acta Chi Belg. 2003;103:379-382.
32. Wilson YG, Davies AH Currie IC, Morgan M, McGrath C, Baird RN, Lamont PM. Vein graft stenosis: incidence and intervention. Eur J Vasc Endovasc Surg. 1996;11:164-169.
33. Mattos MA, van BP, Hodgson KJ, Ramsey DE, Barkmeier LD, Sumner DS. Does correction of stenoses identified with color duplex scanning improve infrainguinal graft patency? J Vasc Surg. 1993;17:54-64.
34. Dougherty MJ, Calligro KD, DeLaurentis DA The natural history of "failing" arterial bypass grafts in duplex surveillance protocol. Ann Vasc Surg 1998;12:255-259.
35. Deleted in proof.
36. Beattie D, Ellis M, Davies AH. Graft Surveillance. In: Beard JD, Murray S. Pathways of Care in Vascular Surgery. Shrewsbury, UK: TFM Publishing: 2002:107-116.
37. Hozetbein TJ, Pomposelli FB, Miller A, Contreras MA, Gibbons GW, Campbell DR, Freeman DV, LoGerfo FW. Results of a policy with arms vein used as the first alternative to an unavailable ipsilateral great saphenous vein for infrainguinal bypass. J Vasc Surg. 1996;23: 130-140.
38. Harris PL, Veith FJ, Shanik GD, Nott D, Wengerter KR, Moore DJ. Prospective randomised trial of in situ and reversed infrapopliteal vein grafts. Br J Surg. 1993;80:173-176.
39. Singh S, Evans, Datta D, Gaines P, Beard JD. The costs of managing lower limb-threatening ischaemia. Eur J Vasc Endovasc Surg. 1996;12:359-362.
40. Wixon CL, Mills JL, Westerband A, Hughes JD, Ihnat DM. An economic appraisal of lower extremity bypass graft maintenance. J Vasc Surg. 2000;32:1-12.